Comm Eye Health Vol. 27 No. 88 2014 pp 70 - 71. Published online 01 April 2015.

Diseases at the back of the eye

Related content

Age-related macular degeneration (AMD)

Exudative age-related macular degenerative. ICEH
Exudative age-related macular degenerative. ICEH
Early atrophic age-related macular degeneration. ICEH
Early atrophic age-related macular degeneration. ICEH

History

Exudative AMD. Distortion, rapid loss of central and reading vision

Atrophic AMD. Gradual loss of central vision

Examination

Exudative AMD. Blood, or exudate, or scarring at macula

Atrophic AMD. Atrophy of choroid and retinal pigment at macula

Management

Exudative AMD. Refer for intravitreal injections (if available) if:

  • Symptoms are present for less than three months
  • Vision is better than counting fingers (CF)

Atrophic AMD. No treatment is available, but patients may benefit from low vision aids

Information for Patients

Exudative AMD. If suitable for treatment, patients will require three injections over three months. They are likely to need more injections after the initial three. Even if no further treatment is needed, they will need to attend the clinic every two months


Open-angle glaucoma

Open-angle glaucoma - early cupping. ICEH
Open-angle glaucoma – early cupping. ICEH
Open-angle glaucoma - cupped disc. ICEH
Open-angle glaucoma – cupped disc. ICEH

History

Initially no symptoms, then gradual loss of the peripheral field of vision which can lead to loss of central vision

Examination

Pale and cupped disc, constricted visual fields, may have elevated intraocular pressure (IOP)

Management

Treatment cannot improve sight, so refer only if the patient still has useful vision

Aim to reduce IOP using:

  • Daily eye drops
  • Surgery
  • Laser

Information for Patients

The sight will not be improved by treatment, which aims to prevent further loss of vision.

Eye drops must be used every day, and continued indefinitely.

Surgery or laser may lower the IOP permanently but will require frequent examinations for the first three months


Diabetic retinopathy (DR)

Diabetic maculopathy. ICEH
Diabetic maculopathy. ICEH
Diabetic new vessels (proliferative DR). ICEH
Diabetic new vessels (proliferative DR). ICEH

History

Initially no symptoms, then:
Maculopathy. Gradual loss of central vision
Proliferative DR. Sudden or gradual loss of vision

Examination

Maculopathy. Exudates near macula
Proliferative DR. New vessels or vitreous haemorrhage

Management

Maculopathy. Refer for laser or intravitreal injections if vision is 6/60 or better

Proliferative DR. Refer for laser if any new vessels or vitreous haemorrhage. May need vitrectomy if there is vitreous haemorrhage and/or poor vision

Information for Patients

Maculopathy. The injection treatment is the same as for exudative AMD. Laser may lead to a more permanent cure, but still requires examination every 3-4 months

Proliferative DR. After laser, examine the patient every three months for the first year


All three conditions are chronic, and cannot be completely cured. We expect anti-VEGF injections to improve vision in exudative AMD and diabetic maculopathy in most – but not all – patients. In glaucoma and proliferative DR, treatment will only prevent the condition getting worse. In order to manage these chronic and incurable disorders effectively, patients must attend the clinic regularly for the rest of their lives


Also available to download as a high-resolution A3 size poster